vs
FIRST COMMUNITY CORP(FCCO)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
FIRST COMMUNITY CORP的季度营收约是STANDARD BIOTOOLS INC.的1.2倍($23.2M vs $19.6M),FIRST COMMUNITY CORP净利率更高(23.7% vs -177.4%,领先201.1%),过去两年FIRST COMMUNITY CORP的营收复合增速更高(19.1% vs -12.2%)
第一社区(南卡罗来纳州)旗下的联合社区银行是一家美国银行,也是美国东南部规模领先的综合性金融机构,目前拥有277亿美元资产,在阿拉巴马州、佛罗里达州、佐治亚州、北卡罗来纳州、南卡罗来纳州和田纳西州共设有200家网点,按资产计算是总部设于南卡罗来纳州的最大银行。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
FCCO vs LAB — 直观对比
营收规模更大
FCCO
是对方的1.2倍
$19.6M
净利率更高
FCCO
高出201.1%
-177.4%
两年增速更快
FCCO
近两年复合增速
-12.2%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $23.2M | $19.6M |
| 净利润 | $5.5M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | — | -168.5% |
| 净利率 | 23.7% | -177.4% |
| 营收同比 | — | -11.5% |
| 净利润同比 | 37.6% | -28.8% |
| 每股收益(稀释后) | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FCCO
LAB
| Q1 26 | $23.2M | — | ||
| Q4 25 | $20.6M | — | ||
| Q3 25 | $20.5M | $19.6M | ||
| Q2 25 | $19.5M | $21.8M | ||
| Q1 25 | $18.4M | $40.8M | ||
| Q4 24 | $17.5M | — | ||
| Q3 24 | $17.0M | $22.1M | ||
| Q2 24 | $16.3M | $22.5M |
净利润
FCCO
LAB
| Q1 26 | $5.5M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $5.2M | $-34.7M | ||
| Q2 25 | $5.2M | $-33.5M | ||
| Q1 25 | $4.0M | $-26.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $3.9M | $-26.9M | ||
| Q2 24 | $3.3M | $-45.7M |
毛利率
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% |
营业利润率
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 32.2% | -168.5% | ||
| Q2 25 | 34.2% | -118.1% | ||
| Q1 25 | 28.2% | -80.8% | ||
| Q4 24 | 30.9% | — | ||
| Q3 24 | 29.5% | -120.9% | ||
| Q2 24 | 24.7% | -134.5% |
净利率
FCCO
LAB
| Q1 26 | 23.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 25.4% | -177.4% | ||
| Q2 25 | 26.6% | -153.7% | ||
| Q1 25 | 21.8% | -63.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 22.7% | -122.0% | ||
| Q2 24 | 20.0% | -203.3% |
每股收益(稀释后)
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | $0.62 | — | ||
| Q3 25 | $0.67 | $-0.09 | ||
| Q2 25 | $0.67 | $-0.09 | ||
| Q1 25 | $0.51 | $-0.07 | ||
| Q4 24 | $0.55 | — | ||
| Q3 24 | $0.50 | $-0.07 | ||
| Q2 24 | $0.42 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $220.8M | $399.7M |
| 总资产 | $2.4B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M |
总债务
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M |
股东权益
FCCO
LAB
| Q1 26 | $220.8M | — | ||
| Q4 25 | $167.6M | — | ||
| Q3 25 | $161.6M | $399.7M | ||
| Q2 25 | $155.5M | $424.5M | ||
| Q1 25 | $150.0M | $454.6M | ||
| Q4 24 | $144.5M | — | ||
| Q3 24 | $143.3M | $489.3M | ||
| Q2 24 | $136.2M | $510.3M |
总资产
FCCO
LAB
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | $539.6M | ||
| Q2 25 | $2.0B | $557.0M | ||
| Q1 25 | $2.0B | $579.6M | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | $681.5M | ||
| Q2 24 | $1.9B | $708.7M |
负债/权益比
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | $18.7M | — | ||
| Q3 25 | $9.2M | $-22.2M | ||
| Q2 25 | $-236.0K | $-20.7M | ||
| Q1 25 | $6.4M | $-30.3M | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $10.8M | $-27.9M | ||
| Q2 24 | $-292.0K | $-39.0M |
自由现金流
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | $17.6M | — | ||
| Q3 25 | $9.0M | $-23.1M | ||
| Q2 25 | $-454.0K | $-22.6M | ||
| Q1 25 | $6.2M | $-35.3M | ||
| Q4 24 | $10.5M | — | ||
| Q3 24 | $10.6M | $-30.1M | ||
| Q2 24 | $-634.0K | $-41.0M |
自由现金流率
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | 85.3% | — | ||
| Q3 25 | 44.2% | -118.1% | ||
| Q2 25 | -2.3% | -103.6% | ||
| Q1 25 | 34.0% | -86.6% | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 62.5% | -136.4% | ||
| Q2 24 | -3.9% | -182.2% |
资本支出强度
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | — | ||
| Q3 25 | 0.6% | 4.5% | ||
| Q2 25 | 1.1% | 8.7% | ||
| Q1 25 | 1.1% | 12.4% | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 1.1% | 10.2% | ||
| Q2 24 | 2.1% | 8.6% |
现金转化率
FCCO
LAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.77× | — | ||
| Q2 25 | -0.05× | — | ||
| Q1 25 | 1.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.80× | — | ||
| Q2 24 | -0.09× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FCCO
| Net Interest Income | $18.4M | 79% |
| Noninterest Income | $4.8M | 21% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |